DSKYF Daiichi Sankyo Company, Limited — dividend yield, history & ex-dividend dates
Daiichi Sankyo Company, Limited operates as a global pharmaceutical powerhouse, dedicated to the research, development, manufacturing, and worldwide commercialization of a wide array of medicinal products. The company boasts an extensive portfolio of therapeutics spanning numerous health conditions. In oncology, its offerings include trastuzumab deruxtecan, an innovative anti-HER2 antibody-drug conjugate for cancer treatment, alongside agents such as gefitinib for malignant tumors, bicalutamide for prostate cancer, and tamoxifen for breast cancer. For chronic diseases, Daiichi Sankyo provides mirogabalin for pain management; treatments for type 2 diabetes mellitus like teneligliptin/canagliflozin and teneligliptin; and medications for hypercholesterolemia, including pravastatin and colesevelam (which also addresses type 2 diabetes). Bone health is supported by denosumab for osteoporosis and related conditions, while anemia is managed with ferric carboxymaltose and iron sucrose injections. Its cardiovascular and neurological solutions include the antiplatelet agent prasugrel, the anticoagulant edoxaban, and the antihypertensive olmesartan; as well as lacosamide for epilepsy and memantine for Alzheimer's disease. Other key prescription products address conditions such as ulcers (esomeprazole), influenza (laninamivir), bacterial infections (levofloxacin), dysuria (silodosin), and general pain and inflammation (loxoprofen). Beyond prescription drugs, Daiichi Sankyo also markets a selection of consumer health items. These comprise the multi-symptom cold remedy Lulu, the antipyretic/anti-inflammatory pain reliever Loxonin S, Transino for skin discoloration like melasma and freckles, Minon skincare products, and the oral hygiene brands Breath Labo and Clean Dental. Furthermore, the company produces various vaccines, including those for influenza (both cell culture-derived and HA types), measles, rubella, and mumps. Its diverse operations extend to veterinary pharmaceuticals, cosmetics, medical equipment, food products, drinking water, and the production of active pharmaceutical ingredients (APIs) and chemical intermediates. A significant collaboration involves Guardant Health, with whom Daiichi Sankyo is developing Guardant360 CDx as a companion diagnostic for Enhertu, specifically targeting advanced metastatic non-small cell lung cancer. Established in 1899, this
Dividend Snapshot
Research Scores
Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.
Not Rated
How the Dividend Safety Score is built for DSKYF
| Input | Value | Points | Weight |
|---|---|---|---|
| Earnings payout ratio | Earnings payout ratio 59% (TTM to Jun 30, 2026) | 81 | 20% |
| FCF payout ratio | Free cash flow negative (TTM to Jun 30, 2026) | 0 | 25% |
| Net debt / EBITDA | Net cash (TTM to Jun 30, 2026) | 100 | 15% |
| Interest coverage | Interest coverage 17.5x (TTM to Jun 30, 2026) | 100 | 10% |
| Dividend record | 39 years of uninterrupted regular payments; last cut Sep 29, 2022 (-22.1%), within 10 years: capped at 50 | 50 | 20% |
| Earnings stability | Net income positive in 5 of the last 5 fiscal years (FY2022–FY2026) | 100 | 10% |
Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.
How the Dividend Growth Score is built for DSKYF
| Input | Value | Points | Weight |
|---|---|---|---|
| 5-year dividend growth | 5-year dividend CAGR 14.5% (2020–2025) | 100 | 25% |
| Consecutive annual increases | 3 consecutive annual increases (through 2025) | 45 | 20% |
| Payout headroom | Headroom from the earnings payout ratio 59% (TTM to Jun 30, 2026) | 72 | 20% |
| Earnings per share growth (3 years) | EPS CAGR 35.2% (FY2023–FY2026) | 100 | 15% |
| Revenue growth (3 years) | Revenue CAGR 18.7% (FY2023–FY2026) | 100 | 10% |
| 10-year dividend growth | 10-year dividend CAGR 9.0% (2015–2025) | 95 | 10% |
Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.
Key Metrics
Current Yield
3.32%
At the Oct 30, 2026 price
The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.Annualized Dividend
$0.5632
Declared May 11, 2026
The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.Frequency
S Semi-Annual
How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.RSI (14)
48
As of Oct 30, 2026
Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.52-Week Range
$14.76 – $26.15
Closes through Oct 23, 2026
The lowest and highest price over the past year, showing where today's price sits in its recent range.Payout Ratio (TTM)
59.07%
12 months to Jun 30, 2026 (Q1 FY2027)
The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.Years Paying
40
How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.Price / Book (TTM)
3.01
Price as of Oct 25, 2026; latest reported book value
Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.S.A.F.E. Dividend Read
Quote & Key Data
Dividend Growth
How often a record like this ends in a cut
DSKYF has raised its annual dividend in 27 separate years since March 1987, which ranks 234 among the 2,430 payers with a comparable record in our dataset. In 2 years the annual total fell by more than a fifth.
Of the 310 companies we track with 25 or more years of increases, 173 — 56 per cent — also have at least one year in which the dividend fell by more than 20 per cent. Across every company with twenty years of comparable history, only 277 of 1078 (26 per cent) have never cut. A long record of increases is common; a record with no cut anywhere in it is not.
Measured from annual totals using split-adjusted amounts, comparing only consecutive years with the same number of payments — a stock split and a payment shifting across a year boundary both look like cuts otherwise. The current year is excluded as incomplete. How we measure a cut, and what the corrections change. Figures are for information only, not a view on any security.
Why the Yield Moved (90 Days)
DSKYF's dividend yield rose from 3.26% to 3.32% over the past ~90 days (+0.06 pp). Of that move, +0.00 pp came from changes in the dividend rate and +0.06 pp from the share price ($17.26 on Aug 03, 2026 → $16.97 on Oct 30, 2026). A yield that rises because the price fell is not an improvement in the payout itself.
Yield vs Its Own History
Across 272 daily observations over the past 13 months (through Oct 23, 2026), DSKYF's current yield is higher than approximately 80% of them. Our stored price history for DSKYF covers the past 13 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.
Adjusted Price History
Dividend History
Dividend Payment History
Ex-dividend calendar →| Amount | Type | Declared | Ex-Date | Record | Pay |
|---|---|---|---|---|---|
| $0.3180 S | Regular | May 11, 2026 | Sep 30, 2026 | Sep 30, 2026 | N/A |
| $0.3178 S | Regular | N/A | Sep 29, 2026 | Sep 30, 2026 | Sep 29, 2026 |
| $0.2452 S | Regular | Apr 25, 2025 | Mar 31, 2026 | Mar 31, 2026 | Jun 23, 2026 |
| $0.2636 S | Regular | Apr 25, 2025 | Sep 30, 2025 | Sep 30, 2025 | Dec 10, 2025 |
| $0.2001 S | Regular | Apr 25, 2024 | Mar 31, 2025 | Mar 31, 2025 | Jun 24, 2025 |
| $0.2094 S | Regular | Apr 25, 2024 | Sep 30, 2024 | Sep 30, 2024 | Dec 10, 2024 |
| $0.1982 S | Regular | Apr 27, 2023 | Mar 28, 2024 | Mar 31, 2024 | Jun 18, 2024 |
| $0.1338 S | Regular | Apr 27, 2023 | Sep 28, 2023 | Sep 30, 2023 | Dec 08, 2023 |
| $0.1130 S | Regular | Apr 27, 2022 | Mar 30, 2023 | Mar 31, 2023 | Jun 20, 2023 |
| $0.0940 S | Regular | Apr 27, 2022 | Sep 29, 2022 | Sep 30, 2022 | Dec 01, 2022 |
| $0.1107 S | Regular | Apr 27, 2021 | Mar 30, 2022 | Mar 31, 2022 | Jun 28, 2022 |
| $0.1207 S | Regular | Apr 27, 2021 | Sep 29, 2021 | Sep 30, 2021 | Dec 01, 2021 |
| $0.1225 S | Regular | Apr 27, 2020 | Mar 30, 2021 | Mar 31, 2021 | Jun 22, 2021 |
| $0.3832 S | Regular | Apr 27, 2020 | Sep 29, 2020 | Sep 30, 2020 | Dec 01, 2020 |
| $0.3239 S | Regular | Apr 25, 2019 | Mar 30, 2020 | Mar 31, 2020 | Jun 16, 2020 |
| $0.3239 S | Regular | Apr 25, 2019 | Sep 27, 2019 | Sep 30, 2019 | Dec 02, 2019 |
| $0.3171 S | Regular | N/A | Mar 27, 2019 | Mar 31, 2019 | Jun 18, 2019 |
| $0.3099 S | Regular | N/A | Sep 26, 2018 | Sep 30, 2018 | Dec 03, 2018 |
| $0.3293 S | Regular | N/A | Mar 28, 2018 | Mar 31, 2018 | Jun 19, 2018 |
| $0.3104 S | Regular | N/A | Sep 27, 2017 | Sep 30, 2017 | Dec 01, 2017 |
| $0.3151 S | Regular | N/A | Mar 29, 2017 | Mar 31, 2017 | Jun 20, 2017 |
| $0.3480 S | Regular | N/A | Sep 28, 2016 | Sep 30, 2016 | Dec 01, 2016 |
| $0.2647 S | Regular | N/A | Mar 29, 2016 | Mar 31, 2016 | Jun 21, 2016 |
| $0.3337 S | Regular | N/A | Sep 28, 2015 | Sep 30, 2015 | Dec 01, 2015 |
| $0.2518 S | Regular | N/A | Mar 27, 2015 | Mar 31, 2015 | Jun 23, 2015 |
| $0.2744 S | Regular | N/A | Sep 26, 2014 | Sep 30, 2014 | Dec 01, 2014 |
| $0.2938 S | Regular | N/A | Mar 27, 2014 | Mar 31, 2014 | Jun 24, 2014 |
| $0.3032 S | Regular | N/A | Sep 26, 2013 | Sep 30, 2013 | Dec 02, 2013 |
| $0.3179 S | Regular | N/A | Mar 27, 2013 | Mar 31, 2013 | Jun 24, 2013 |
| $0.3857 S | Regular | N/A | Sep 26, 2012 | Sep 30, 2012 | Dec 03, 2012 |
| $0.3626 S | Regular | N/A | Mar 28, 2012 | Mar 31, 2012 | Jun 25, 2012 |
| $0.3921 S | Regular | N/A | Sep 28, 2011 | Sep 30, 2011 | Dec 01, 2011 |
| $0.3641 S | Regular | N/A | Mar 29, 2011 | Mar 31, 2011 | Jun 28, 2011 |
| $0.3579 S | Regular | N/A | Sep 28, 2010 | Sep 30, 2010 | Dec 01, 2010 |
| $0.3238 S | Regular | N/A | Mar 29, 2010 | Mar 31, 2010 | Jun 29, 2010 |
| $0.3339 S | Regular | N/A | Sep 25, 2009 | Sep 30, 2009 | Dec 01, 2009 |
| $0.4048 S | Regular | N/A | Mar 26, 2009 | Mar 31, 2009 | Jun 29, 2009 |
| $0.3762 S | Regular | N/A | Sep 25, 2008 | Sep 30, 2008 | Dec 01, 2008 |
| $0.3536 S | Regular | N/A | Mar 26, 2008 | Mar 31, 2008 | Jun 30, 2008 |
| $0.3052 S | Regular | N/A | Sep 25, 2007 | Sep 30, 2007 | Dec 03, 2007 |
| $0.2541 S | Regular | N/A | Mar 27, 2007 | Mar 31, 2007 | Jun 29, 2007 |
| $0.2141 A | Regular | N/A | Mar 28, 2006 | Mar 31, 2006 | Jun 30, 2006 |
| $0.2337 S | Regular | N/A | Mar 28, 2005 | Mar 31, 2005 | Jun 30, 2005 |
| $0.1357 S | Regular | N/A | Sep 27, 2004 | Sep 30, 2004 | Dec 10, 2004 |
| $0.1648 S | Regular | N/A | Mar 26, 2004 | Mar 31, 2004 | Jun 30, 2004 |
| $0.1122 S | Regular | N/A | Sep 25, 2003 | Sep 30, 2003 | Dec 10, 2003 |
| $0.1040 S | Regular | N/A | Mar 26, 2003 | Mar 31, 2003 | Jun 30, 2003 |
| $0.1014 S | Regular | N/A | Sep 25, 2002 | Sep 30, 2002 | Dec 10, 2002 |
| $0.0937 S | Regular | N/A | Mar 26, 2002 | Mar 31, 2002 | Jun 28, 2002 |
| $0.1064 S | Regular | N/A | Sep 25, 2001 | Sep 30, 2001 | Dec 10, 2001 |
| $0.0998 S | Regular | N/A | Mar 27, 2001 | Mar 31, 2001 | Jun 29, 2001 |
| $0.1138 S | Regular | N/A | Sep 26, 2000 | Sep 30, 2000 | Dec 08, 2000 |
| $0.1148 S | Regular | N/A | Mar 28, 2000 | Mar 31, 2000 | Jun 30, 2000 |
| $12.2500 S | Regular | N/A | Sep 27, 1999 | Sep 30, 1999 | Dec 06, 1999 |
| $14.7500 S | Regular | N/A | Mar 26, 1999 | Mar 31, 1999 | Jun 30, 1999 |
| $12.2500 S | Regular | N/A | Sep 25, 1998 | Sep 30, 1998 | Dec 07, 1998 |
| $13.3000 S | Regular | N/A | Mar 26, 1998 | Mar 31, 1998 | Jun 29, 1998 |
| $11.2000 S | Regular | N/A | Sep 25, 1997 | Sep 30, 1997 | Dec 08, 1997 |
| $13.4000 S | Regular | N/A | Mar 26, 1997 | Mar 31, 1997 | Jun 30, 1997 |
| $9.0000 S | Regular | N/A | Sep 25, 1996 | Sep 30, 1996 | Dec 09, 1996 |
| $10.6000 S | Regular | N/A | Mar 26, 1996 | Mar 31, 1996 | Jun 28, 1996 |
| $8.0000 S | Regular | N/A | Sep 26, 1995 | Sep 30, 1995 | Dec 11, 1995 |
| $8.2500 S | Regular | N/A | Mar 28, 1995 | Mar 31, 1995 | Jun 30, 1995 |
| $8.0000 S | Regular | N/A | Sep 27, 1994 | Sep 30, 1994 | Dec 12, 1994 |
| $6.2500 S | Regular | N/A | Mar 28, 1994 | Mar 31, 1994 | Jun 30, 1994 |
| $6.2500 S | Regular | N/A | Sep 27, 1993 | Sep 30, 1993 | Dec 10, 1993 |
| $7.5000 S | Regular | N/A | Mar 26, 1993 | Mar 31, 1993 | Jun 30, 1993 |
| $5.0000 S | Regular | N/A | Sep 25, 1992 | Sep 30, 1992 | Dec 10, 1992 |
| $6.2500 S | Regular | N/A | Mar 26, 1992 | Mar 31, 1992 | Jun 29, 1992 |
| $3.7500 S | Regular | N/A | Sep 25, 1991 | Sep 30, 1991 | Dec 10, 1991 |
| $6.2500 S | Regular | N/A | Mar 26, 1991 | Mar 31, 1991 | Jun 28, 1991 |
| $3.7500 S | Regular | N/A | Sep 25, 1990 | Sep 30, 1990 | Dec 10, 1990 |
| $3.7500 S | Regular | N/A | Mar 27, 1990 | Mar 31, 1990 | Jun 29, 1990 |
| $3.7500 S | Regular | N/A | Sep 26, 1989 | Sep 30, 1989 | Jan 16, 1990 |
| $5.2500 S | Regular | N/A | Mar 28, 1989 | N/A | Jul 16, 1989 |
| $3.7500 S | Regular | N/A | Sep 27, 1988 | N/A | Jan 16, 1989 |
| $3.7500 S | Regular | N/A | Mar 28, 1988 | N/A | Jul 16, 1988 |
| $3.7500 S | Regular | N/A | Sep 26, 1987 | N/A | Jan 16, 1988 |
| $3.7500 S | Regular | N/A | Mar 27, 1987 | N/A | Jul 16, 1987 |
1 future payment listed by our data provider without a declaration is a projection, so it is not listed here or shown as a last or next dividend.
Peer Comparison
Selected Drug Manufacturers - General dividend payers we cover, strongest DividendRank first — for context, not a recommendation.
| Ticker | Name | Yield | 5-Yr Growth | Streak | Rank |
|---|---|---|---|---|---|
| ZTS | Zoetis Inc. | 2.69% | 20.1% | 11 yrs | 94 |
| BMY | Bristol-Myers Squibb Company | 4.10% | 6.6% | 18 yrs | 86 |
| ALPMY | Astellas Pharma Inc. | 3.10% | 5.6% | 11 yrs | 80 |
| ALPMF | Astellas Pharma Inc. | 2.87% | 5.9% | 3 yrs | 80 |
Related Guides & Lists
DSKYF dividend — frequently asked questions
Does Daiichi Sankyo Company, Limited pay a dividend?
Yes. Daiichi Sankyo Company, Limited (DSKYF) currently pays a dividend. The annualized dividend is about $0.56 per share, a yield of approximately 3.32%.
What is Daiichi Sankyo Company, Limited's dividend yield?
Daiichi Sankyo Company, Limited's dividend yield is approximately 3.32%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.
How often does Daiichi Sankyo Company, Limited pay dividends?
Daiichi Sankyo Company, Limited pays dividends semi-annually — 2 times per year.
How long has Daiichi Sankyo Company, Limited paid dividends?
Daiichi Sankyo Company, Limited has 40 years of dividend payments on record, and has increased its dividend for 3 consecutive years.
Data updated Oct 30, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.